New Brighton, MN, United States of America

Max A Kruziki

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: 3M Innovative Properties Company. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Max A Kruziki: Innovator in Medical Compositions

Introduction

Max A Kruziki is a notable inventor based in New Brighton, MN (US). He has made significant contributions to the field of medical compositions, particularly in the area of microbial virulence suppression. His innovative work has the potential to impact the treatment of microbial infections.

Latest Patents

Max A Kruziki holds a patent for "Phosphate-containing copolymers for virulence suppression." This patent involves phosphate-containing copolymers, medical compositions containing these copolymers, and methods for suppressing microbial virulence. By suppressing virulence, the administration and application of these medical compositions can be utilized to prevent, mitigate, or treat microbial infections. The copolymers are prepared by phosphorylating either a random copolymer or a random copolymeric block that contains monomeric units of propylene oxide and glycidol. He has 1 patent to his name.

Career Highlights

Max A Kruziki is associated with 3M Innovative Properties Company, where he has been able to apply his expertise in developing innovative medical solutions. His work at 3M has allowed him to contribute to advancements in healthcare and medical technology.

Collaborations

Throughout his career, Max has collaborated with notable colleagues, including Carl A Laskowski and Timothy M Gillard. These collaborations have further enriched his work and contributed to the development of effective medical compositions.

Conclusion

Max A Kruziki is a distinguished inventor whose work in phosphate-containing copolymers has the potential to revolutionize the treatment of microbial infections. His contributions to 3M Innovative Properties Company and collaborations with esteemed colleagues highlight his commitment to innovation in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…